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Abstract
Background: Coordinated differentiation of the endometrial compartments in the second half of the
menstrual cycle is a prerequisite for the establishment of pregnancy. Endometrial stromal cells (ESC)
decidualize under the influence of ovarian progesterone to accommodate implantation of the blastocyst
and support establishment of the placenta. Studies into the mechanisms of decidualization are often
hampered by the lack of primary ESC. Here we describe a novel immortalized human ESC line.
Methods: Primary ESC were immortalized by the transduction of telomerase. The resultant cell line,
termed St-T1b, was characterized for its morphological and biochemical properties by
immunocytochemistry, RT-PCR and immunoblotting. Its progestational response was tested using
progesterone and medroxyprogesterone acetate with and without 8-Br-cAMP, an established inducer of
decidualization in vitro.
Results: St-T1b were positive for the fibroblast markers vimentin and CD90 and negative for the epithelial
marker cytokeratin-7. They acquired a decidual phenotype indistinguishable from primary ESC in response
to cAMP stimulation. The decidual response was characterized by transcriptional activation of marker
genes, such as PRL, IGFBP1, and FOXO1, and enhanced protein levels of the tumor suppressor p53 and
the metastasis suppressor KAI1 (CD82). Progestins alone had no effect on St-T1b cells, but
medroxyprogesterone acetate greatly enhanced the cAMP-stimulated expression of IGFBP-1 after 3 and
7 days. Progesterone, albeit more weakly, also augmented the cAMP-induced IGFBP-1 production but only
after 7 days of treatment. The cell line remained stable in continuous culture for more than 150 passages.
Conclusion: St-T1b express the appropriate phenotypic ESC markers and their decidual response closely
mimics that of primary cultures. Decidualization is efficiently induced by cAMP analog and enhanced by
medroxyprogesterone acetate, and, to a lesser extent, by natural progesterone. St-T1b cells therefore
serve as a useful model for primary ESC.
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Background
Decidualization is a differentiation process of endome-
trial stromal cells (ESC) that, in humans, is initiated in the
secretory phase of the menstrual cycle independently of a
blastocyst signal. The transformation of elongated stromal
fibroblasts into secretory epithelioid-like decidual cells is
first apparent approximately 10 days after the postovula-
tory surge in circulating progesterone (P4) levels in the
vicinity of terminal spiral arteries and then spreads
throughout the endometrial compartment through auto-
crine and paracrine signals. Typical secretory products of
decidualized cells are IGFBP-1 and prolactin (PRL).
Induction of IGFBP1 and decidua-specific PRL gene tran-
scription serve as molecular markers of decidualization
[1-3]. Furthermore, expression of the forkhead transcrip-
tion factor FOXO1 is induced with decidualization, both
in vivo and in vitro [4], and levels of the tumor suppressor
protein p53 and the tetraspanin KAI1 (CD82), a cell sur-
face protein that functions as a metastasis suppressor in
tumor cells, are increased posttranscriptionally in decidu-
alized cells [5-7].
Investigations into the mechanisms of decidualization in
humans are largely restricted to cell culture experimenta-
tion. Yet such studies are hampered by difficulties in
obtaining tissues for the preparation of primary decidual
cell cultures. Consequently, attempts have been made to
immortalize human endometrial stromal cells by onco-
genic transformation. However, SV40-transformed cells
display genomic instability [8] and, with time in culture,
lose the crucial capability of undergoing decidual differ-
entiation in response to the appropriate stimuli (our own
unpublished observations on the St-2 cell line described
in [9]). Recently, the use of human telomerase reverse
transcriptase (hTERT) as the immortalizing agent for ESCs
has yielded more promising results [10,11].
Normal primary cells undergo senescence because linear
chromosomes shorten progressively with every round of
replication unless the ends of the chromosomes, the tel-
omers, are maintained by telomerase, a reverse tran-
scriptase that adds telomeric repeats de novo after each
cell division. While human tumor cells often have aber-
rantly high telomerase levels, most differentiated adult
cells display silencing of telomerase activity, leading to
progressive telomere shortening and thus a limited
lifespan [12]. The re-introduction of telomerase into pri-
mary cells can bestow them with extension of replicative
lifespan or even immortalization without the characteris-
tics of neoplastic transformation such as anchorage-inde-
pendent growth and lack of contact inhibition [13,14].
Telomerase-immortalized ESC lines have been shown to
undergo decidualization in response to extended treat-
ment with 17β-estradiol (E2) and medroxyprogesterone
acetate (MPA), or upon sequential stimulation with epi-
dermal growth factor (EGF), E2 and MPA [10,11].
In the present study, we characterize a new telomerase-
immortalized ESC line, termed St-T1b. The ability of these
cells to undergo decidualization and their stability in
long-term culture are investigated to validate the cell line
as a model for primary ESC.
Methods
Cell culture
Primary cultures of human ESC were prepared from ano-
nymized uterine biopsy samples obtained from premeno-
pausal women (age 35–50) at the time of hysterectomy
for benign gynecological disorders. Purified ESC were pre-
pared as previously described [15] and maintained in ESC
medium: phenolred-free Dulbecco's modified Eagle
medium (DMEM)/Ham's F12 with 10% steroid-depleted
dialyzed fetal bovine serum (FCS) (PAA Laboratories,
Cölbe, Germany), 100 U/ml penicillin, 100 μg/ml strep-
tomycin, and 0.2% Primocin (Invivogen, San Diego, CA),
and supplemented with insulin (1 μg/ml) and 17β-estra-
diol (E2; 1 nM) (Sigma-Aldrich, Deisenhofen, Germany).
Decidualization was performed in minimal medium 1
(MM1; ESC medium without insulin or E2) in the pres-
ence of 0.5 mM 8-Br-cAMP (Biolog, Bremen, Germany).
The local ethics committee approved this study and
patient consent was obtained before tissue collection.
Immortalization of primary ESC was performed in collab-
oration with Gordon Peters (Cancer Research UK London
Research Institute, London, UK). ESC were isolated from
a biopsy taken during the proliferative phase from a 30
year old patient with tubal disease awaiting IVF treatment.
Briefly, the receptor for ecotropic retroviruses was first sta-
bly introduced into the primary ESC using neomycin
selection, then the cells were infected with a retrovirus
encoding hTERT and selected for hygromycin resistance.
The pBABE retrovirus system was used in which the cDNA
of interest is driven by the Moloney murine leukemia
virus promoter in the viral long terminal repeat and the
marker is driven by the SV40 promoter [16]. St-T1b cells
were maintained and decidualized in the same media as
described for ESC, but in the absence of Primocin. Stimu-
lations with P4, MPA, dexamethasone (all from Sigma-
Aldrich) and R5020 (Promegestone; PerkinElmer,
Rodgau, Germany) were performed in MM1. With the
exception of the long-term observation, all experiments
were performed repeatedly between passage numbers 30
and 53, and representative experiments are shown.
The trophoblastic hybridoma cell line AC-1M88, a fusion
of primary extravillous trophoblast from term placenta
with a mutant of the JEG-3 choriocarcinoma cell line, was
kindly provided by H.G. Frank and P. Kaufmann (Univer-
sity Hospital Aachen, Germany) [17,18], and was main-
tained in DMEM/Ham's F12 with 10% complete FCS, 100
U/ml penicillin, and 100 μg/ml streptomycin.R
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Table 1: Oligonucleotide Primers and Amplification Conditions for RT-PCR
Amplified Product Forward/Reverse Primer Amplification Conditions Product Size Genbank Accession No.
DEPP
(C10orf10)
5'-AGGTCCCGGCTTCTGCTCTCC-3'
5'-CCCATGGGCTTGCTGCTGTC-3'
20 cycles
95°C 30 sec, 60°C 30 sec, 72°C 45 sec
434 bp NM_007021
dPRL
(decidua-specific PRL transcript)
5'-GAGACACCAAGAAGAATCGGAACATACAGG-3'
5'-TCGGGGGTGGCAAGGGAAGAA-3'
25 or 30 cycles
94°C 45 sec, 57°C 45 sec, 72°C 45 sec
416 bp M58594,
GQ305133
ERα
(ESR1)
5'-CCCGCCGGCATTCTACA-3'
5'-ACATTCTCCCTCCTCTTCGGTCTT-3'
30 cycles
95°C 30 sec, 52°C 30 sec, 72°C 45 sec
359 bp NM_000125
GAPDH 5'-GGAGTCCACTGGCGTCTTCAC-3'
5'-GAGGGGCCATCCACAGTCTTCT-3'
20 cycles
95°C 30 sec, 65°C 30 sec, 72°C 30 sec
287 bp NM_002046
HEF-1
(NEDD9)
5'-AACCGGGTGAAGCTTCTGATTGG-3'
5'-GCTGATGAGGGAGGGATGTCGTAT-3'
25 cycles
95°C 45 sec, 62°C 45 sec, 72°C 60 sec
416 bp NM_006403
IGFBP-1 5'-TGCTGCAGAGGCAGGGAGCCC-3'
5'-AAGGATCCTCTTCCCATTCCA-3'
25 cycles
95°C 30 sec, 63°C 30 sec, 72°C 90 sec
378 bp NM_000596
ITGA6 5'-AGCAAGGCAGATGGAATAATGTGA-3'
5'-AGGCCGGGATCTGAAAATAGTT-3'
25 cycles
95°C 45 sec, 55°C 45 sec, 72°C 60 sec
329 bp NM_000210
KAI-1
(CD82)
5'-AGAAGTGGGCCCTGTGACC-3'
5'-TTGCCCATGTTGAAGTAGAAGAG-3'
25 cycles
95°C 30 sec, 58°C 30 sec, 72°C 90 sec
396 bp NM_002231
p53
(TP53)
5'-TTCCACGACGGTGACACGCTT-3'
5'-GTAGCTGCCCTGGTAGGTTTTCTG-3'
25 cycles
95°C 30 sec, 57°C 30 sec, 72°C 45 sec
381 bp NM_000546
PR-B
(PGR)
5'-GCCACATTCAACACCCACTTTCTC-3'
5'-GCCTCCAGCACCCCTTGTAGC-3'
30 cycles
95°C 45 sec, 52°C 45 sec, 72°C 60 sec
411 bp NM_000926
PR-B/-A 5'-TCCACGTGCCTATCCTGCCTCTCA-3'
5'-GCCGTCACCGCCGCTTCC-3'
30 cycles
95°C 45 sec, 61°C 45 sec, 72°C 60 sec
412 bp NM_000926
PR-LBD 5'-GGACATGACAACACAAAACCTGAC-3'
5'-GTGCCCGGGACTGGATAAAT-3'
30 cycles
95°C 45 sec, 52°C 45 sec, 72°C 60 sec
598 bp NM_000926
Tissue Factor
(F3)
5'-TACTTGGCACGGGTCTTCTCCTAC-3'
5'-TTCTCCTGGCCCATACACTCTACC-3'
20 cycles
95°C 30 sec, 60°C 30 sec, 72°C 45 sec
431 bp NM_001993Reproductive Biology and Endocrinology 2009, 7:76 http://www.rbej.com/content/7/1/76
Page 4 of 11
(page number not for citation purposes)
Immunocytochemistry
Cells grown on 8-well chamber slides (BD Biosciences,
Heidelberg, Germany) were fixed with 4% paraformalde-
hyde, blocked for endogenous peroxidase activity (0.75%
H2O2 in methanol for 10 min at room temperature), and
then immunostained with mouse monoclonal antibodies
to vimentin (Clone V9, 1:1,000) (Dako, Hamburg, Ger-
many), CD90 (Clone AS02, 1:100) (Dianova, Hamburg,
Germany), or cytokeratin-7 (CK7) (Clone OV-TL, 1:200)
(Dako). Immunoreactivity was visualized with 3,3'-
diaminobenzidine tetrahydrochloride (DAB; brown)
(Vectastain ABC-Elite-Universal:HRP Kit; Linaris).
Actin staining with FITC phalloidin
Cultured cells were fixed with 4% paraformaldehyde for
10 min at room temperature, washed with PBS for 10
min, and permeabilized with 0.1% Triton X-100 in PBS
for 10 min. Following three washes in PBS for 10 min
each, cells were incubated in PBS/1% BSA for 25 min. Flu-
orescein-phalloidin (Invitrogen, Karlsruhe, Germany)
stock solution (200 U/ml in methanol) was diluted 1:40
in PBS/1% BSA and placed on the monolayer for 20 min.
After three washes in PBS, cells were mounted in ProLong
Gold antifade reagent (Invitrogen).
RNA extraction and RT-PCR
RNA was extracted from cultured cells with peqGold
RNApure reagent (Peqlab, Erlangen, Germany) according
to the manufacturer's protocol, but the aqueous phase
obtained after chloroform extraction was subjected to an
additional purification step by phenol/chloroform/iso-
amylalcohol extraction. One μg of RNA was used for
oligo(dT)-primed cDNA synthesis with the ImProm-II
Reverse Transcription System (Promega, Mannheim, Ger-
many). Of the resulting 20 μl of cDNA, 0.5 μl were used
per semi-quantitative PCR reaction. Unless indicated oth-
erwise, 20 μl PCR reaction mix contained 1 × Taq buffer
(5PRIME; VWR International, Darmstadt, Germany), 0.2
mM dNTPs, 2 pmol sense and antisense primers, 1 M
betain, and 0.2 μl 5PRIME Taq DNA polymerase (VWR
International); for amplification of steroid hormone
receptor cDNAs, 0.1 μl BioTherm Taq DNA polymerase
(Genecraft, Lüdinghausen, Germany) was used. All pro-
grams started with a denaturation step at 95°C for 4 min
and terminated with an elongation step at 72°C for 10
min. For amplification of dPRL cDNA, Hot Start Taq DNA
polymerase (0.1 μl) was used with the corresponding
buffer (Qiagen, Hilden, Germany) and a denaturation
step at 95°C for 15 min. Specific amplification conditions
and primer sequences are given in Table 1. PCR products
were resolved in 2% agarose gels, stained with SYBR Gold
(Molecular Probes, Invitrogen) and visualized in a
Typhoon 8600 Imager (Amersham Biosciences, Freiburg,
Germany).
Western blot
Whole cells extracts were prepared in RIPA buffer (10 mM
Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% sodium
deoxycholate, 1% Triton X-100, 0.1% SDS) with Com-
plete protease inhibitors (Roche Applied Science, Man-
nheim, Germany). Proteins were electrophoresed on 10%
SDS-polyacrylamide gels (NuPage Bis-Tris; Invitrogen)
and transferred by tank-blotting onto polyvinylidene dif-
luoride Immobilon membranes (Millipore, Eschborn,
Germany). For electrophoresis and transfer under non-
reducing conditions, RIPA lysates were added to an equal
volume of loading buffer without β-mercaptoethanol (10
mM Tris, 10% SDS, 25% glycerol, 0.01% bromophenol
blue), and antioxidant was omitted from the NuPAGE
transfer buffer (Invitrogen). For reducing conditions, 25%
β-mercaptoethanol was included in the loading buffer,
and electrotransfer was carried out in the presence of
0.25% antioxidant. Immunodetection was performed
with the enhanced chemiluminescence system (SuperSig-
nal; Pierce, Bonn, Germany). KAI1 was detected under
non-reducing conditions (antibody TS82b, 1:500) (Dia-
clone, Besançon, France). GAPDH (6C5, 1:10,000)
(HyTest, Turku, Finland) and p53 (DO-1, 1:1,000) (Cal-
biochem, Darmstadt, Germany) were detected under
reducing conditions. For analysis of FOXO1, cells were
directly extracted into hot loading buffer, and equal vol-
umes loaded per lane for reducing gel electrophoresis. The
rabbit monoclonal FOXO1 antibody C29H4 (Cell Signal-
ing Technology, Danvers, MA) was used at 1:1,000.
IGFBP-1 ELISA
St-T1b cells were plated at a density of 4 × 105 cells per
well in 6-well-plates. Two days later, media were changed,
and cells received stimuli (8-Br-cAMP, P4 or MPA alone or
in combination) or MM1 alone for 4 d. Media were
changed again, all cells received stimuli, and 3 d later
supernatants were harvested for measurement of IGFBP-1
secretion, and total RNA was extracted from the monolay-
ers. Every treatment was done in triplicate wells. Secreted
IGFBP-1 was measured by ELISA (Mediagnost, Reutlin-
gen, Germany) (detection range: 0.1 – 8 ng/ml) and nor-
malized to total RNA.
Statistical analysis
GraphPad Prism software was used to perform one-way
ANOVA, followed by Bonferroni's post-hoc test.
Results
Phenotypic characterization of the endometrial stromal 
cell line, St-T1b
St-T1b cells were initially characterized approximately 30
passages after immortalization with hTERT. First, we
examined cell type-specific antigen expression of these
fibroblast-derived cells. Vimentin and CD90 were used asReproductive Biology and Endocrinology 2009, 7:76 http://www.rbej.com/content/7/1/76
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fibroblast markers and contrasted to cytokeratin-7 (CK7)
as an epithelioid marker (Fig. 1). St-T1b cells were found
to display the appropriate phenotype being vimentin+/
CD90+/CK7-. The trophoblast-derived cell line AC-1M88
served as a positive control for CK7 staining and lack of
vimentin and CD90 immunoreactivity.
Characteristics of St-T1b cells: response to cAMP
St-T1b cells were treated with 8-Br-cAMP, a widely estab-
lished stimulus for decidualization [1]. Morphological
decidualization was evident by phase contrast microscopy
and upon staining of the actin cytoskeleton, showing the
same reorganization from elongated to polygonal shape
in St-T1b cells as seen in primary ESC (Fig. 2A). St-T1b
cells were also compared to primary ESC for their ability
to express typical marker genes of decidualization, namely
those coding for decidual PRL (dPRL) and IGFBP-1. Max-
imum induction of dPRL and IGFBP-1 transcripts was
seen after 3 d of cAMP treatment, and induction was
maintained for at least 7 d in both cell systems (Fig. 2B).
Furthermore, treatment with 8-Br-cAMP over a 7-day
time-course induced a gradual increase in both p53 and
KAI1 proteins but not mRNA levels (Fig. 3). In summary,
the cAMP responses of St-T1b cells closely reflected those
of primary ESC.
Long-term maintenance of St-T1b cells
We wondered if the cells retained their ability to decidual-
ize in extended culture. Cells obtained at passage number
30 were therefore maintained in continuous culture for
more than 113 additional passages. At intervals, a 3-day
decidualization experiment was performed, measuring
the relative induction of dPRL, IGFBP-1 and FOXO1 tran-
scripts as the endpoints (Fig. 4A). The induction of dPRL
mRNA was clearly detectable up to passage 82 and then
began to weaken. IGFBP-1 transcripts were less robustly
induced and faded around passage number 72. St-T1b dis-
played a cAMP-dependent induction of FOXO1 message
levels throughout the entire study period with a decline at
later passages. This was reflected by a decrease in cAMP-
induced FOXO1 protein levels when comparing passage
numbers 44 and 114. The response to cAMP was not
altered by the addition of P4 or P4 plus E2 over 7 d (Fig.
4B). Morphological features of decidualization, and
vimentin expression, were still maintained at passage 114
(Fig. 4C).
The doubling time of St-T1b cells was determined to be
approximately 24 h. No growth crisis was apparent
throughout the entire period of observation.
Characteristics of St-T1b cells: response to progesterone
We next assessed the expression of the nuclear receptors
for ovarian steroid hormones, namely progesterone recep-
tor (PR) and estrogen receptor (ER). The expression of PR
was tested in the absence and presence of P4, as it has
been reported that liganded PR activates its own promoter
in human ESC [19]. Using primers to various regions of
the PR, namely to the N-terminus specific to the full
length PR-B, to a region common to PR-B and the N-ter-
minally truncated PR-A isoform, and to the ligand-bind-
ing domain (LBD) of PR [20], expression of PR was
readily detectable in both St-T1b cells and ESC. Likewise,
ERα transcripts were amplified from both cell types. Tran-
script levels were not altered by P4 treatment (Fig. 5A).
ERβ transcripts were below the limit of detection in both
cell systems (data not shown).
To further explore the P4 responsiveness of St-T1b cells,
we turned to a panel of established genes under the tran-
scriptional control of the activated PR isoforms, PR-A, PR-
B or both. These included tissue factor (TF; gene F3) and
integrin α6 (ITGA6) as PR-B target genes [21], decidual
protein induced by progesterone (DEPP; C10orf10) as a
PR-B/PR-A target gene [22,23], HEF-1 (NEDD9) as a PR-A
target gene [21], and promyelocytic leukemia zinc finger
protein (PLZF; ZBTB16) as a product rapidly induced by
P4 in ESC [24]. RNA was harvested after 4 and 24 h of
treatment with P4, the synthetic progestin R5020 (Prome-
gestone), or the glucocorticoid receptor (GR) agonist dex-
amethasone, and subjected to semiquantitative RT-PCR
Phenotypic markers of St-T1b cells Figure 1
Phenotypic markers of St-T1b cells. St-T1b were grown 
to near confluency and subjected to immunocytochemical 
analysis using antibodies to vimentin, CD90 and cytokeratin-
7 (CK7). The trophoblast-derived cell line AC-1M88 was 
stained alongside as a control. Control insets (Co) shows 
staining with omission of the primary antibody (original mag-
nification, 100×).Reproductive Biology and Endocrinology 2009, 7:76 http://www.rbej.com/content/7/1/76
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for the above targets (Fig. 5B). None of the transcripts was
induced in response to P4 or R5020. In contrast, dexame-
thasone weakly up-regulated HEF-1 mRNA after 4 h but
had a strong and sustained effect on PLZF mRNA expres-
sion. This is consistent with our previous observation that
PLZF expression is regulated not only by P4 but also by
glucocorticoids [24]. The absence of a transcriptional
response to P4 prompted us to examine the expression of
PR isoforms in St-T1b cells at the protein level. Neither
PR-B nor PR-A were detectable by Western blotting in this
cell line (data not shown). Thus, undifferentiated St-T1b
cells are responsive to glucocorticoid but not to P4 as they
seem to lack PR protein. In agreement, P4 treatment, in
combination with E2, failed to induce morphological
changes associated with decidualization in St-T1b cells
(data not shown).
At physiologic concentrations, P4 has a half-life of only 2–
4 h in cells, and even at 1 μM, the steroid is entirely metab-
olized within 18 h, whereas synthetic progestins including
MPA are not metabolized [25]. Owing to its higher stabil-
ity as compared to P4, MPA is frequently used in the
extended treatments of ESC to induce the decidual reac-
tion. We therefore compared the two progestins, P4 and
MPA, alone and in combination with cAMP analog. St-
T1b cells were treated for 3 or 7 d before supernatants and
Morphological and biochemical decidualization of St-T1b cells Figure 2
Morphological and biochemical decidualization of St-T1b cells. A) The left panel shows phase contrast microphoto-
graphs of untreated (control) or decidualized St-T1b cells after 7 d treatment with 8-Br-cAMP (magnification, 100×). Right 
panel: St-T1b cells and primary ESC were left untreated or exposed to 8-Br-cAMP for 4 d before staining with FITC-phalloidin 
to visualize the cytoskeleton (200×). B) St-T1b cells and ESC were cultured for 1, 3, or 7 d in the absence or presence of 8-Br-
cAMP. Induction of transcripts for decidualization markers dPRL and IGFBP-1 was demonstrated by RT-PCR; GAPDH mRNA 
was amplified for normalization.
Induction of KAI1 and p53 protein expression in decidualiz- ing St-T1b cells Figure 3
Induction of KAI1 and p53 protein expression in 
decidualizing St-T1b cells. A) Total protein was har-
vested from St-T1b cells after 1, 3, or 7 d of treatment with 
8-Br-cAMP and from untreated cells. Western blot analysis 
was performed for KAI1 and p53, and for GAPDH as a load-
ing control. B) RNA was harvested from the same cultures 
as described in panel A and analyzed for KAI1, p53 and 
GAPDH transcript levels by RT-PCR.Reproductive Biology and Endocrinology 2009, 7:76 http://www.rbej.com/content/7/1/76
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RNA were harvested (Fig. 6A). RT-PCR analysis of dPRL,
IGFBP-1, FOXO1 and DEPP transcript levels revealed
induction of all targets by cAMP after 3 d but not in
response to progestin treatment alone for 3 or 7 days (Fig.
6B). However, different patterns of responses were
observed for combined treatments. FOXO1 and dPRL
mRNA were induced by cAMP after 3 and 7 d to similar
degrees; this was not altered by the presence of P4 but
minutely enhanced by MPA. For DEPP mRNA, on the
other hand, the cAMP response seen after 3 d was reduced
after 7 d, but recovered both by addition of P4 and MPA.
Induction of IGFBP-1 in response to cAMP stimulation
was transient, characterized by lower expression levels
after 7 compared to 3 days of stimulation (see also Fig. 2).
The decline in the expression of this decidual marker gene
after 7 days of cAMP stimulation was entirely reversed
upon co-treatment with P4 and even more so with MPA.
These findings indicate a synergy between cAMP and MPA
at both time points, and most importantly, the acquisi-
tion of P4-responsiveness after 7 days of exposure to
cAMP. The supernatants of the above cultures were also
assayed for secreted IGFBP-1. Remarkably, the expression
profile seen at the mRNA level was precisely reflected at
the protein level and clearly underpinned the significant
reduction in cAMP-stimulated IGFPB-1 expression after 7
d, and a reversal of this reduction by added P4 at the later
time point. Again, the most effective combination was
that of cAMP with MPA (Fig. 6C). Secreted PRL levels were
below the level of detection of the ELISA.
Taken together, cAMP-primed St-T1b cells are responsive
to the synthetic progestin MPA and, upon extended induc-
tion of the decidual process, acquire responsiveness to P4.
Further experiments were undertaken to assess the role of
E2. Over a 7 d stimulation, the induction of IGFPB-1,
dPRL and FOXO1 expression obtained with cAMP alone,
cAMP plus P4, or cAMP plus MPA was not enhanced by
E2. No induction was obtained with steroids alone. More-
over, morphology of the cells was not altered by the addi-
tion of E2. Western blot analysis of the samples shown in
Fig. 4B revealed no induction of PR protein in decidual-
ized cells by E2 (data not shown).
Discussion
Validated stable ESC lines are in demand to overcome the
limitations in obtaining primary endometrial tissues for
cell culture experimentation. In addition to an extended
lifespan, the ability to undergo decidualization is of fore-
most importance in ESC lines. Here we characterize the St-
T1b cell line that was generated from primary human ESC
by introducing hTERT. The line has been maintained in
Long-term maintenance of St-T1b cells Figure 4
Long-term maintenance of St-T1b cells. A) St-T1b cells, obtained at passage number 30, were kept in continuous culture 
for the indicated number of passages and tested for their ability to decidualize in response to 3 d of 8-Br-cAMP stimulus. Tran-
script levels of dPRL, IGFBP-1 and FOXO1 were determined by RT-PCR; GAPDH mRNA was amplified for normalization. B) 
St-T1b cells at passage number 44 or 114 were treated with the indicated combinations of 8-Br-cAMP, P4 (1 μM) and E2 (10 
nM) for 7 d before Western blot analysis for FOXO1. The blot was stripped and reprobed with GAPDH antibody. C) St-T1b 
cells at passage number 114, untreated or treated with 8-Br-cAMP for 7 d, were subjected to immunocytochemistry with 
vimentin antibody (original magnification, 100×).Reproductive Biology and Endocrinology 2009, 7:76 http://www.rbej.com/content/7/1/76
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continuous culture for more than 150 passages now with-
out signs of crisis. It displays the typical morphology of
proliferative endometrial fibroblasts and expresses the
appropriate lineage-specific markers like vimentin and
CD90 while being CK7-negative. In response to cAMP
stimulation, the cells decidualize as judged by morpho-
logical alteration and activation of dPRL, IGFBP-1 and
FOXO1 expression. Furthermore, as we have shown previ-
ously for primary ESC, these cells respond to cAMP by up-
regulating KAI1 and p53 proteins [26,4,6,5]. A widely
used protocol for decidualization is treatment of ESC with
E2 plus P4 for up to 14 d [27-30]. Furthermore, P4 serves
to enhance the action of cAMP analog as a decidualization
stimulus [1]. A stable ESC line that expresses PR and dis-
plays P4-responsiveness would therefore be highly desira-
ble. In St-T1b cells, however, despite the presence of PR
transcripts, no morphological or biochemical deciduali-
zation was seen in response to even prolonged P4/E2
treatment (data not shown). Further, a range of PR target
genes was not activated in St-T1b cells upon short-term P4
stimulation, and PR protein was not detectable. We have
previously observed lack of a P4 response in an ESC line
immmortalized with SV40 large T antigen [9]. Likewise,
ESC cells immortalized with a temperature-sensitive SV40
large T antigen could readily be stimulated to decidualize
in response to cAMP analog, but not P4 [31]. Loss of PR
expression with time in culture is also seen in primary ESC
[23]. It thus appears that PR expression does not offer a
selective advantage to ESC in long-term culture.
On the other hand, an ESC line immortalized with telom-
erase was reported to mount a normal progestational
response [10]. However, it has to be noted that neither
expression of PR protein nor a response to P4 were specif-
ically assessed in this cell line; rather it was shown that the
cells decidualize in response to E2 plus MPA, a progestin
capable of activating the androgen receptor (AR) and GR
in addition to PR [32,25]. For another telomerase-immor-
talized ESC line, SHT290, a long sequential treatment pro-
tocol with epidermal growth factor (EGF), E2 and MPA
was employed to induce decidualization [11]. An SV40-
transformed ESC line, HIESC, was shown not only to
decidualize upon combined treatment with cAMP plus
MPA, but also to express PR as determined by Western
blot analysis [33]. The particular PR antibody used in that
study, however, yields non-specific bands and may cause
misleading results [20]. These aforementioned studies
suggest the possibility that AR rather than PR mediates the
effect of MPA on decidualization in these cell lines. Of
note, we recently demonstrated a non-redundant role of
AR in decidualizing ESC. Activation of AR by dihydrotes-
tosterone (DHT) enhanced the decidual response trig-
gered by cAMP plus P4 signaling [34].
Here, we demonstrate for the first time a response to nat-
ural P4 in an immortalized ESC line. The transient induc-
tion of IGFBP-1 expression and secretion by cAMP,
declining after 7 days of treatment, was completely recov-
ered by addition of P4. Our findings on regulation of
IGFBP-1 expression precisely reflect what has been
described before in primary ESC: cAMP alone rapidly
induces decidualization but is not sufficient to sustain the
decidual phenotype over an extended period of time. The
long-term maintenance of decidualization is achieved by
the addition of P4 to cAMP-primed ESC, and is even fur-
ther enhanced by DHT [34]. This combinatorial effect of
cAMP, P4 and DHT might explain the strong effect seen in
our system by the combination of cAMP and MPA, sug-
gesting that MPA acts through both the PR and the AR.
Steroid hormone receptor expression and P4 responsiveness  in St-T1b cells Figure 5
Steroid hormone receptor expression and P4 
responsiveness in St-T1b cells. A) Expression of PR and 
ERα was analyzed by RT-PCR in St-T1b cells and ESC cul-
tured without or with P4 (1 μM) for 4 h. PR transcripts were 
amplified using primers recognizing specifically PR-B, a region 
common to PR-B and PR-A, or the ligand-binding domain 
(LBD). GAPDH mRNA was amplified as a loading control. B) 
Expression of P4 target genes was analyzed in St-T1b cells by 
RT-PCR, after 4 or 24 h treatment with the indicated doses 
of P4, dexamethasone or R5020. Controls received 0.001% 
ethanol as a vehicle control.Reproductive Biology and Endocrinology 2009, 7:76 http://www.rbej.com/content/7/1/76
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Effect of P4 and MPA on expression of decidual products Figure 6
Effect of P4 and MPA on expression of decidual products. A) St-T1b cells were incubated in MM1 for 9 days as out-
lined in the scheme. Cultures were stimulated for 3 or 7 d with 8-Br-cAMP (0.5 mM) alone or in combination with P4 or MPA 
(1 μM). Supernatants were collected from the last 3 days of treatment, and RNA was harvested. B) RT-PCR analysis was per-
formed for the indicated products on cells that had been stimulated for 3 or 7 d. C) Supernatants of the cultures described 
above, stimulated for 3 or 7 d, were assayed for IGFBP-1. Values represent IGFBP-1 secretion over 3 d, normalized to total 
RNA content of the wells. Means ± SD are shown (n = 3 wells). ANOVA followed by Bonferroni's post-hoc test revealed signif-
icant differences (**, P < 0.01; ***, P < 0.001; s, significantly different from controls, P4 and MPA after 3 and 7 d with P < 0.001; 
ns, not significantly different from controls, P4 or MPA after 3 and 7 d).Reproductive Biology and Endocrinology 2009, 7:76 http://www.rbej.com/content/7/1/76
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While we failed to detect PR protein by Western blot anal-
ysis in decidualized St-T1b cells, in the absence or pres-
ence of E2, the receptor may still be present at a low level
that is sufficient to elicit a response. Alternatively, the P4
signal may be transduced through other, still enigmatic,
non-classical receptors [35].
It is remarkable that a decidual product believed to be
exquisitely dependent on P4 stimulation, DEPP, was
instead induced by 8-Br-cAMP in St-T1b cells. A signifi-
cant overlap of products induced by cAMP analog with
those induced by P4 treatment had also been revealed by
gene expression profiling of primary ESC [36], underpin-
ning the concept of intricate crosstalk between the two sig-
naling pathways, and partial redundancy, in
decidualization [1].
Conclusion
We have characterized a telomerase-immortalized ESC
line, St-T1b, that displays many features of primary ESC.
Morphological and biochemical decidualization was
achieved by cAMP treatment. While the cells did not
respond to short-term P4 treatment by up-regulation of
established P4 target genes, we could demonstrate that the
cells acquired P4-responsiveness upon prolonged treat-
ment with cAMP, and that the steroid supported mainte-
nance of the cAMP-induced decidual phenotype. We
therefore consider this cell line a valid substitute for pri-
mary ESC in the investigation into decidual transforma-
tion and function.
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